Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Characterization of the CBir1 antigenic response for diagnosis and treatment of Crohn's disease

Characterization of the CBir1 antigenic response for diagnosis and treatment of Crohn's disease

US Patent 8153443 · Granted Apr 10, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunotherapy for the treatment and prevention of inflammatory bowel disease2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Signature of TL1A (TNFSF15) signaling pathway2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Diagnosis and treatment of inflammatory bowel disease2024
Diagnosis and treatment of inflammatory bowel disease2024
Diagnosis and treatment of inflammatory bowel disease2024
Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel2024
Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel2024
Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel2024
Kit comprising contiguous nucleobases, including position 76, of RS57459942024
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof2024